Professor Farid Saad
Bayer AG, Berlin (Germany)
Follow
Biography
Farid Saad worked for various pharmaceutical companies as specialist for reproductive endocrinology, pediatric endocrinology, andrology, endocrinology of male aging, and hormonal male contraception in clinical development, scientific and global medical affairs. He retired in 2019 and keeps working as a consultant for Bayer AG in Germany.
Farid Saad has authored and co-authored more than 150 peer-reviewed papers and more than 700 scientific abstracts.
He received honorary professorships in clinical research and endocrinology at Gulf Medical University, Ajman, U.A.E., and at Men’s Health Reproduction Study Center, Hang Tuah University, Surabaya, Indonesia, and serves as a lecturer at Dresden International University, Dresden, Germany.
Contributor content
Presentation
Improvements of blood pressure, heart rate, and pulse pressure in men with hypogonadism and type 2 diabetes, with and without long-term testosterone therapy
Presentation
Improved glycaemic control and reduced incidence of myocardial infarctions, strokes, and mortality in men with hypogonadism and type 2 diabetes, with and without long-term testosterone therapy
Presentation
Effect of testosterone therapy on cardiovascular risk factors, major adverse cardiovascular events and mortality in men with functional hypogonadism and cardiovascular disease in a real-world registry
Presentation
Significant reduction of Framingham risk score in hypogonadal men receiving long-term testosterone therapy: real-life evidence from a 10-year registry
Presentation
Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study
Presentation
